back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-11-12 19:41 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
460,000 | ||
| Filed 2024-11-12 19:40 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
1,200,000 | ||
| Filed 2024-11-12 19:39 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
1,513,985 | ||
| Filed 2024-11-10 20:20 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
170,000 | ||
| Filed 2024-11-10 20:14 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
237,300 | ||
| Filed 2024-11-10 20:13 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
24,000 | ||
| Filed 2024-11-10 20:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,000 | ||
| Filed 2024-11-10 20:10 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30,400 | ||
| Filed 2024-11-10 20:04 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,187,500 | ||
| Filed 2024-11-08 14:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-08 14:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,006,100 | ||
| Filed 2024-09-11 11:59 Tx date 2024-09-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,044
+400 vol $2.61 each |
224,865 | |
| Filed 2024-09-11 11:57 Tx date 2024-09-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,095
+1,500 vol $2.73 each |
224,465 | |
| Filed 2024-07-01 23:10 Tx date 2024-06-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,800
+14,800 vol $3.50 each |
1,212,466 | |
| Filed 2024-06-17 16:09 Tx date 2024-06-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,926
+1,100 vol $2.66 each |
222,965 | |
| Filed 2024-06-12 12:08 Tx date 2024-06-11 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,248
+800 vol $2.81 each |
221,865 | |
| Filed 2024-06-09 21:38 Tx date 2024-06-07 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,730
+1,000 vol $2.73 each |
221,065 | |
| Filed 2024-05-30 16:04 Tx date 2024-05-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$191,000
+50,000 vol $3.82 each |
495,000 | |
| Filed 2024-05-24 00:26 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
195,000 | |
| Filed 2024-05-24 00:23 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
||
| Filed 2024-05-22 23:41 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,200
+70,000 vol $3.96 each |
190,000 | |
| Filed 2024-05-22 23:33 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
262,500 | |
| Filed 2024-05-22 23:31 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
193,750 | |
| Filed 2024-05-22 23:29 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$693,000
+175,000 vol $3.96 each |
449,250 | |
| Filed 2024-05-22 23:23 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,200
+70,000 vol $3.96 each |
250,000 | |
| Filed 2024-05-22 23:21 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,584,000
+400,000 vol $3.96 each |
1,034,250 | |
| Filed 2024-05-22 23:17 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$138,600
+35,000 vol $3.96 each |
445,000 | |
| Filed 2024-05-22 23:13 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
186,250 | |
| Filed 2024-05-22 23:09 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
170,000 | |
| Filed 2024-05-22 23:05 Tx date 2024-05-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,920
+640 vol $3.00 each |
220,065 | |
| Filed 2024-03-22 18:01 Tx date 2024-01-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-178,488.8861
-31,877 vol $5.60 each |
48,725 | |
| Filed 2024-03-22 15:55 Tx date 2024-01-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-286,855.3386
-39,846 vol $7.20 each |
265,775 | |
| Filed 2024-01-12 16:35 Tx date 2024-01-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$28,000
+4,000 vol $7.00 each |
4,000 | |
| Filed 2024-01-12 16:34 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-12 16:33 Tx date 2024-01-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-28,000
-4,000 vol $7.00 each |
4,626 | |
| Filed 2023-08-20 13:03 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,010
+1,430 vol $7.00 each |
7,680 | |
| Filed 2023-08-20 12:02 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$35,000
+5,000 vol $7.00 each |
27,200 | |
| Filed 2023-08-20 11:31 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$28,000
+4,000 vol $7.00 each |
8,626 | |
| Filed 2023-08-20 10:41 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$19,999
+2,857 vol $7.00 each |
219,425 | |
| Filed 2023-08-20 01:08 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$56,000
+8,000 vol $7.00 each |
8,000 | |
| Filed 2023-08-20 01:07 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-20 00:58 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Holder: Liberty Bell Holdings Ltd (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,002
+14,286 vol $7.00 each |
14,286 | |
| Filed 2023-08-20 00:57 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Holder: Liberty Bell Holdings Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-20 00:54 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,200
+3,600 vol $7.00 each |
106,596 | |
| Filed 2023-08-20 00:40 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$525,000
+75,000 vol $7.00 each |
1,197,666 | |
| Filed 2023-08-20 00:35 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,002
+14,286 vol $7.00 each |
674,012 | |
| Filed 2023-08-20 00:29 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,001
+7,143 vol $7.00 each |
46,343 | |
| Filed 2023-05-19 19:30 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,231,200
+180,000 vol $6.84 each |
180,000 | |
| Filed 2023-05-19 19:28 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-31 19:02 Tx date 2023-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,692
+400 vol $4.23 each |
39,200 | |
| Filed 2023-03-31 19:01 Tx date 2023-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,725
+2,100 vol $4.16 each |
38,800 | |
| Filed 2023-03-31 19:00 Tx date 2023-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.00
+100 vol $4.10 each |
36,700 | |
| Filed 2023-03-31 18:59 Tx date 2023-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$164,400
+400 vol $411.00 each |
36,600 | |
| Filed 2023-03-31 18:58 Tx date 2023-03-30 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,250
+2,000 vol $4.13 each |
36,200 | |
| Filed 2023-03-31 14:10 Tx date 2023-03-30 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,725
+900 vol $4.14 each |
22,200 | |
| Filed 2023-03-31 14:09 Tx date 2023-03-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,310
+9,100 vol $4.10 each |
21,300 | |
| Filed 2023-03-30 13:47 Tx date 2022-12-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-176,025.994
-22,006 vol $8.00 each |
305,621 | |
| Filed 2023-03-29 11:22 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,894
+700 vol $4.14 each |
659,726 | |
| Filed 2023-03-29 11:21 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,463
+600 vol $4.11 each |
659,026 | |
| Filed 2023-03-29 11:19 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,680
+4,800 vol $4.10 each |
658,426 | |
| Filed 2022-12-13 15:22 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
150,000 | |
| Filed 2022-12-12 20:26 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$462,000
+120,000 vol $3.85 each |
120,000 | |
| Filed 2022-12-12 20:25 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-12 20:22 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
125,000 | |
| Filed 2022-12-12 20:20 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
134,508 | |
| Filed 2022-12-12 20:05 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
217,500 | |
| Filed 2022-12-12 20:03 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+90,000 vol $3.85 each |
274,250 | |
| Filed 2022-12-12 20:01 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
148,750 | |
| Filed 2022-12-12 19:58 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+90,000 vol $3.85 each |
274,250 | |
| Filed 2022-12-12 19:58 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+90,000 vol $3.85 each |
||
| Filed 2022-12-12 19:55 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$731,500
+190,000 vol $3.85 each |
634,250 | |
| Filed 2022-12-12 19:50 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
141,250 | |
| Filed 2022-12-12 12:36 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+90,000 vol $3.85 each |
410,000 | |
| Filed 2021-11-19 15:17 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
||
| Filed 2022-11-02 19:28 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2022-11-02 19:26 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,200 | ||
| Filed 2022-09-07 16:47 Tx date 2022-09-07 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,750
+4,500 vol $1.50 each |
1,122,666 | |
| Filed 2022-09-07 16:46 Tx date 2022-09-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+1,600 vol $1.50 each |
1,118,166 | |
| Filed 2022-08-25 02:39 Tx date 2022-08-22 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,819
+6,800 vol $1.15 each |
653,626 | |
| Filed 2022-08-22 12:47 Tx date 2022-08-19 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$770.00
+700 vol $1.10 each |
646,826 | |
| Filed 2022-08-20 11:20 Tx date 2022-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,925
+8,500 vol $1.05 each |
646,126 | |
| Filed 2022-08-17 17:38 Tx date 2022-08-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,625
+2,500 vol $1.05 each |
637,626 | |
| Filed 2022-07-02 12:36 Tx date 2022-06-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+9,900 vol $1.00 each |
635,126 | |
| Filed 2022-06-14 16:27 Tx date 2022-06-14 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+10,000 vol $1.20 each |
625,226 | |
| Filed 2022-06-09 01:45 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,041
+900 vol $1.16 each |
216,568 | |
| Filed 2022-06-09 01:44 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$579.10
+500 vol $1.16 each |
215,668 | |
| Filed 2022-06-09 01:44 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,991
+18,000 vol $1.17 each |
215,168 | |
| Filed 2022-06-09 01:43 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$119.48
+100 vol $1.19 each |
197,168 | |
| Filed 2022-06-09 01:42 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,198
+1,000 vol $1.20 each |
197,068 | |
| Filed 2022-06-09 01:42 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,991
+5,000 vol $1.20 each |
196,068 | |
| Filed 2022-06-09 01:41 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$67,872
+56,560 vol $1.20 each |
191,068 | |
| Filed 2022-05-12 17:01 Tx date 2022-05-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,000
+150,000 vol $1.06 each |
2,784,049 | |
| Filed 2022-05-12 16:58 Tx date 2022-05-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,000
+150,000 vol $1.06 each |
2,784,049 | |
| Filed 2022-05-12 16:54 Tx date 2022-05-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,000
+150,000 vol $1.06 each |
2,661,122 | |
| Filed 2022-05-04 17:40 Tx date 2022-05-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,946
+164,875 vol $0.03 each |
2,798,924 | |
| Filed 2022-05-04 17:37 Tx date 2022-05-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,946
+164,875 vol $0.03 each |
2,798,924 | |
| Filed 2022-05-04 17:15 Tx date 2022-05-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,946
+164,875 vol $0.03 each |
2,675,997 | |
| Filed 2022-05-03 20:17 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+153,659 vol |
153,659 | |
| Filed 2022-05-03 20:16 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:16 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+153,659 vol |
153,659 | |
| Filed 2022-05-03 20:15 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:14 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+2,634,049 vol |
2,634,049 | |
| Filed 2022-05-03 20:13 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:13 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,634,049 vol |
2,634,049 | |
| Filed 2022-05-03 20:12 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Frank, Morgan
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:06 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+138,293 vol |
138,293 | |
| Filed 2022-05-03 20:04 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:04 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+138,293 vol |
138,293 | |
| Filed 2022-05-03 20:03 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:02 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+2,634,049 vol |
2,634,049 | |
| Filed 2022-05-03 20:01 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 20:01 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,634,049 vol |
2,634,049 | |
| Filed 2022-05-03 19:59 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Besser, James
6 - Director or Senior Officer of 10% Security Holder
Holder: Manchester Management Company LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 19:52 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Jeb Partners L.P. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+122,927 vol |
122,927 | |
| Filed 2022-05-03 19:51 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Jeb Partners L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 19:50 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Jeb Partners L.P. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$252,000
+122,927 vol $2.05 each |
122,927 | |
| Filed 2022-05-03 19:48 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Jeb Partners L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 19:45 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+2,511,122 vol |
2,511,122 | |
| Filed 2022-05-03 19:42 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-03 19:41 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,147,800
+2,511,122 vol $2.05 each |
2,511,122 | |
| Filed 2022-05-03 19:30 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Manchester Management Company, LLC
3 - 10% Security Holder of Issuer
Holder: Manchester Explorer, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-23 01:38 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$9,000
+30,000 vol $0.30 each |
180,000 | |
| Filed 2022-04-23 01:37 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$52,500
+30,000 vol $1.75 each |
615,226 | |
| Filed 2022-04-23 01:36 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$1,461
+48,725 vol $0.03 each |
80,602 | |
| Filed 2022-04-23 01:34 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$85,268
+48,725 vol $1.75 each |
102,996 | |
| Filed 2022-04-22 21:12 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$73,170
+243,900 vol $0.30 each |
327,627 | |
| Filed 2022-04-22 21:11 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$426,825
+243,900 vol $1.75 each |
1,116,566 | |
| Filed 2022-04-22 21:10 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$73,170
+243,900 vol $0.30 each |
||
| Filed 2022-04-22 21:07 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$426,825
+243,900 vol $1.75 each |
||
| Filed 2022-04-22 21:05 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$30,000
+100,000 vol $0.30 each |
100,000 | |
| Filed 2022-04-22 21:03 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-22 21:02 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$175,000
+100,000 vol $1.75 each |
100,000 | |
| Filed 2022-04-22 20:43 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-14 16:31 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+243,900 vol |
||
| Filed 2022-04-14 16:19 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$499,994
+243,900 vol $2.05 each |
||
| Filed 2022-04-14 16:31 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+243,900 vol |
327,627 | |
| Filed 2022-04-14 16:19 Tx date 2022-04-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$499,994
+243,900 vol $2.05 each |
1,116,566 | |
| Filed 2022-04-01 19:02 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,945
+2,208 vol $2.24 each |
585,226 | |
| Filed 2022-04-01 19:01 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,575
+2,500 vol $2.23 each |
583,018 | |
| Filed 2022-04-01 19:01 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,998
+2,272 vol $2.20 each |
580,518 | |
| Filed 2022-04-01 19:00 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$876.00
+400 vol $2.19 each |
578,246 | |
| Filed 2022-04-01 19:00 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,917
+1,396 vol $2.09 each |
577,846 | |
| Filed 2022-04-01 18:59 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,416
+1,700 vol $2.01 each |
576,450 | |
| Filed 2022-04-01 18:54 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$269,800
+142,000 vol $1.90 each |
444,250 | |
| Filed 2022-04-01 18:51 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$119,700
+63,000 vol $1.90 each |
184,250 | |
| Filed 2022-04-01 18:47 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$119,700
+63,000 vol $1.90 each |
320,000 | |
| Filed 2022-02-04 17:48 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
61,852 | ||
| Filed 2021-03-12 14:08 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-17 16:58 Tx date 2021-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+5,500 vol $1.80 each |
34,200 | |
| Filed 2021-12-15 15:17 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
135,000 | |
| Filed 2021-12-13 16:19 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
202,500 | |
| Filed 2021-12-13 12:56 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
110,000 | |
| Filed 2021-12-13 12:49 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
133,750 | |
| Filed 2021-12-13 12:46 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
126,250 | |
| Filed 2021-12-09 14:30 Tx date 2021-12-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,600
+10,800 vol $2.00 each |
872,666 | |
| Filed 2021-12-08 13:57 Tx date 2021-12-07 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,800
+12,400 vol $2.00 each |
861,866 | |
| Filed 2021-12-08 13:56 Tx date 2021-12-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,600
+26,800 vol $2.00 each |
849,466 | |
| Filed 2021-11-19 15:17 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
134,508 | |
| Filed 2021-10-26 19:07 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$24,396
+3,050 vol $8.00 each |
68,050 | |
| Filed 2021-10-26 19:05 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,525 vol |
1,525 | |
| Filed 2021-10-26 18:58 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-27 11:29 Tx date 2021-09-21 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,694
+3,700 vol $2.62 each |
28,700 | |
| Filed 2021-09-24 16:58 Tx date 2021-09-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,536
+2,100 vol $2.16 each |
109,444 | |
| Filed 2021-09-24 16:58 Tx date 2021-09-14 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,463
+42,344 vol $2.16 each |
107,344 | |
| Filed 2021-08-24 15:50 Tx date 2021-08-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,967
+650 vol $3.03 each |
574,750 | |
| Filed 2021-08-24 15:49 Tx date 2021-08-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$321.00
+100 vol $3.21 each |
574,100 | |
| Filed 2021-08-24 15:48 Tx date 2021-08-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,508
+24,000 vol $3.02 each |
574,000 | |
| Filed 2021-08-12 15:03 Tx date 2021-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+54,271 vol |
54,271 | |
| Filed 2021-08-12 15:02 Tx date 2021-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-202,959 vol |
0 | |
| Filed 2021-06-10 18:37 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-202,959 vol |
||
| Filed 2021-06-10 18:33 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+54,271 vol |
||
| Filed 2021-06-10 18:21 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-202,959 vol |
||
| Filed 2021-08-06 19:10 Tx date 2021-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-242,737 vol |
0 | |
| Filed 2021-08-06 19:09 Tx date 2021-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+52,945 vol |
822,666 | |
| Filed 2021-06-10 18:07 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+52,945 vol |
||
| Filed 2021-06-10 18:01 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-242,737 vol |
||
| Filed 2021-06-10 19:09 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,056,000
+257,000 vol $8.00 each |
257,000 | |
| Filed 2021-06-10 18:37 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-202,959 vol |
0 | |
| Filed 2021-06-10 18:33 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+54,271 vol |
54,271 | |
| Filed 2021-06-10 18:28 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-10 18:21 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-202,959 vol |
||
| Filed 2021-06-10 18:07 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+52,945 vol |
822,666 | |
| Filed 2021-06-10 18:01 Tx date 2021-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
36 - Conversion or exchange
|
-242,737 vol |
0 | |
| Filed 2021-05-26 15:15 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$2,056,000
+257,000 vol $8.00 each |
||
| Filed 2021-05-26 15:15 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$2,056,000
+257,000 vol $8.00 each |
257,000 | |
| Filed 2021-05-26 14:42 Tx date 2021-05-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-18 17:37 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
12,500 | ||
| Filed 2021-03-18 17:35 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
31,877 | ||
| Filed 2021-03-18 17:34 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$12.50
+12,500 vol $0.001 each |
||
| Filed 2021-03-18 15:35 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
00 - Opening Balance-Initial SEDI Report
|
202,959 | ||
| Filed 2021-03-18 15:22 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2021-03-12 19:18 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 19:11 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$12.50
+12,500 vol $0.001 each |
||
| Filed 2021-03-12 19:02 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Convertible Loan
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 19:00 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-16 19:03 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Holder: held jointly with spouse (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-03-16 19:01 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-16 18:59 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Convertible Loan
00 - Opening Balance-Initial SEDI Report
|
242,737 | ||
| Filed 2021-03-16 18:55 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$980,637
+122,595 vol $8.00 each |
769,721 | |
| Filed 2021-03-16 18:53 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Notes
36 - Conversion or exchange
|
$
-$122,595 vol $8.00 each |
$0 | |
| Filed 2021-03-16 18:45 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Notes
00 - Opening Balance-Initial SEDI Report
|
$122,595 | ||
| Filed 2021-03-15 17:48 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 17:48 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-03-15 17:22 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$3,100,000
+387,500 vol $8.00 each |
487,500 | |
| Filed 2021-03-15 17:20 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2021-03-15 12:39 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$43.75
+21,875 vol $0.002 each |
178,160 | |
| Filed 2021-03-15 12:36 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$349,956
+43,750 vol $8.00 each |
647,126 | |
| Filed 2021-03-12 19:22 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
100,500 | ||
| Filed 2021-03-12 19:21 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-03-12 19:18 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-03-12 19:17 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
116,250 | ||
| Filed 2021-03-12 19:15 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$1,350,000
+168,750 vol $8.00 each |
302,250 | |
| Filed 2021-03-12 19:11 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$12.50
+12,500 vol $0.001 each |
44,377 | |
| Filed 2021-03-12 19:08 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
133,500 | ||
| Filed 2021-03-12 19:07 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
550,000 | ||
| Filed 2021-03-12 19:06 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$199,975
+25,000 vol $8.00 each |
233,750 | |
| Filed 2021-03-12 19:02 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Convertible Loan
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2021-03-12 19:00 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
31,877 | ||
| Filed 2021-03-12 18:57 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
208,750 | ||
| Filed 2021-03-12 15:27 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$349,956
+43,750 vol $8.00 each |
||
| Filed 2021-03-12 15:02 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$349,956
+43,750 vol $8.00 each |
||
| Filed 2021-03-12 14:08 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
156,285 | ||
| Filed 2021-03-12 14:04 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2021-03-12 13:54 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$300,000
+37,500 vol $8.00 each |
123,750 | |
| Filed 2021-03-12 13:52 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
86,250 | ||
| Filed 2021-03-12 13:52 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
603,376 | ||
| Filed 2021-03-12 13:40 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2021-03-12 13:38 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$440,000
+55,000 vol $8.00 each |
192,500 | |
| Filed 2021-03-12 13:34 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
137,500 | ||
| Filed 2021-03-12 13:34 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,626 | ||
| Filed 2021-03-12 12:54 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2021-03-12 12:36 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$240,000
+30,000 vol $8.00 each |
100,000 | |
| Filed 2021-03-12 12:30 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,000 | ||
| Filed 2021-03-12 12:29 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
| Filed 2021-03-11 14:44 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$600,000
+75,000 vol $8.00 each |
121,250 | |
| Filed 2021-03-11 14:38 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2021-03-11 14:37 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
93,421 | ||
| Filed 2021-03-11 14:36 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
46,250 | ||
| Filed 2021-03-11 14:34 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Exchangeable Class B Shares of Eupraxia Pharma, Inc.
00 - Opening Balance-Initial SEDI Report
|
562,500 | ||
| Filed 2021-03-11 14:28 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Malone, Amanda Michelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2021-03-10 17:27 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,250 | ||
| Filed 2021-03-10 17:24 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,250 | ||
| Filed 2021-03-10 17:24 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-10 17:12 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,125 | ||
| Filed 2021-03-10 17:12 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,125 | ||
| Filed 2021-03-10 17:10 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-10 17:10 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-10 17:08 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 |